![Wendy K. Wee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Wendy K. Wee
No más puestos en curso
Perfil
Wendy K.
Wee worked as a Controller, Chief Financial & Accounting Officer at Telik, Inc. from 2013 to 2014.
She completed her undergraduate degree at San Jose State University and earned an MBA from the University of Phoenix.
Antiguos cargos conocidos de Wendy K. Wee.
Empresas | Cargo | Fin |
---|---|---|
Telik, Inc.
![]() Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Director Financiero/CFO | 08/07/2014 |
Formación de Wendy K. Wee.
San Jose State University | Undergraduate Degree |
University of Phoenix | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Telik, Inc.
![]() Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Wendy K. Wee